___

• 1. Wolff SP. Diabetes mellitus and free radicals. Br Med Bull 1993; 49: 642-652. 2. Sinclair AJ. Free radical mechanisms and vascular complication of diabetes mellitus. Diabetes 3. Nerup J, Mandrup-Poulsen T, Helwuist S, Andersen HU, Pociot F, Reimers JI, Cuartero BG, Karlsen AE, Bjerre U, Lorenzen T. On the pathonenesis of IDDM. Diabetologia 1994; 37: 82-89. 4. Packer L. The role of antioxidative treatment in diabetes mellitus. Diabetologia 1993; 36: 1212- 1213. 5. Pieper GM, Jordan M, Donadlinger LA, Adams MB, Roza AM. Peroxidative stress in diabetic blood vessels. Diabetes 1995; 44: 884-889. 6. Griesmacher A, Kindhauser M, Andert SE, Schreiner W, Tomo C, Kroebl P, Pietschmann P, Prager R, Schnack C, Schernthaner G, Mueller M. Enhanced Serum levels of thiobarbituric acid - reactive substances in diabetes mellitus. Am J Med 1995; 98: 469-475. 7. Salonen JT, Myyssönen K, Toumainen TP, Maenpaa PH, Korpela H, Kaplan GA, Lynch J, Helmrich SP, Salonen R. Increased risk of noninsulin dependent diabetes mellitus at low plasma vitamin E concentrations: a four year follow up study in men. Br Med J 1995; 311: 1124-1127. 8. Giugliano D, Ceriello A. Oxidative stress and diabetic vascular complications. Diabetes care 1996; 19: 257-267. 9. World Health Organization Study Group: Diabetes Mellitus, Technical Report Series 1985; 727. 10.Beutler E, Durgun O, Kelly BM. Improved method for the determination of blood glutathione. J Lab Clin Med 1963; 51: 882-888. 11.Sun Y, Oberley LW, Li Y. A simple metod for clinical assay of superoxide dismutase. Clin Chem 1988; 34: 497-500. 12.Paglia DE, Valentine WN. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 1967; 70: 158-69. 13.Omaye ST, Turnbull JD, Souberlich HE. Selected methods for the determination of ascorbic acid in animal cells, tissues and fluids. Methods Enzymol.1979; 6: 3-13. 14.Quaife ML, Scriimshahaw NS, Lowry OH. A micromethod for assay of total tocopherols in blood serum. J Biol Chem 1949; 180: 1220-35. 15.Godin DV, Wohaieb SA, Garnett ME, Goumeniouk AD. Antioxidant enzyme alterations in experimental and clinical diabetes. Mol Cell Biochem 1988; 44:223-231. 16.Sundaram RK, Bhaskar A, Vijayalingom S, Viswanathan M, Mohan R, Shanmugasundaram KR. Antioxidant status and lipid peroxidation in type II diabetes mellitus with and complications. Clin Sci 1996; 9:255-260. 17.Wohaieb SA, Godin DV. Alterations in free radical tissue-defense mechanisms in streptozotocininduced diabetes in rat. Effects of insulin treatment. Diabetes 1987; 36:1014-17. 18.Peuchant E, Beauvieux MCD, Couchouron A, Dubougr L, Thomas MJ, Perromat A, Clerc M, Gin H. Short-term insulin therapy and normoglycemia. Diabetes Care 1997; 20: 202-207. 19.Yoshida K, Hirokawa j, Tagami S, Kawakami Y, Urata Y, Kondo T. Weakened cellular scavenging activity against oxidative stress in diabetes mellitus: regulation of glutathione synthesis and efflux. Diabetologia 1995; 38: 201-210. 20.Wayner DDM, Burton GW, Ingold KU, Barclay LRC, Locke SJ. The relative contributions of vitamin E, urate, ascorbate and proteins to the total peroxyl radical-trapping antioxidant activity of human blood plasma.Biochim Biophys Acta 1987; 924: 408-419. 21. Jacques PF, Chylack LT, McGandy RB, Hartz SC. Antioxidant status in persons with and without senile cataract. Arch Ophthalmol 1988;106: 337-340. 22.Subrahmanyam V.Mantha, Marion P, Jawahar K, Kailash P. Antioxidant enzymes in hypercholesterolemia and effects of vitamin E in Rabbits. Atherosclerosis 1993; 101:135-144. 23.Mclennan S, Yue DK, Fisher E, Hefferan CPS, Ross GR, Turtle JR. Deficiency of ascorbic acid in experimental diabetes. Diabetes 1988; 37: 359-361. 24.Asayama K, Nakane T, Uchida N; Dobashi K, Nakazawa S. Serum antioxidant status in streptozotocin- induced diabetic rat. Horm Metab Res 994; 26: 313-315. 25.Ndahimana J, Docrhy H, Vertongen F. Erythrocyte and plasma antioxidant activity in diabetes mellitus type 1. Presse Med 1996; 25: 188-92. 26.Sinclair AJ, Girling AJ, Gray L, Le Guen C, Lunec J, Barnett AH. Disturbed handling of ascorbic acid in diabetic patients with and without microangiopathy during high dose ascorbate supplementation. Diabetologia 1991; 34: 171- 175. 27.Som S, Basu S, Mukherjee D, Deb S, Choudary R, Mukherjee S, Chatterjee SM, Chatterjee IB. Ascorbic acid metabolism in diabetes mellitus. Metabolism 1981; 30: 572-577. 28.Ruiz C, Alegria A, Barbera R, Farre R, Lagarda MJ. Lipid peroxidation and antioxidant enzyme activities in patients with type 1 diabetes mellitus. Scand J Clin Lab Invest 1999; 59: 99-105. 29.Yue DK, McLennan S, Fisher E, Heffernan S, Copogreco C, Ross GR, Turtle JR. Ascorbic acid metabolism and the polyol pathway. Diabetes 1989; 38: 257-261.